avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfic
|
ENSMUSG00000055053.11 | nuclear factor I/C |
Nfib
|
ENSMUSG00000008575.11 | nuclear factor I/B |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfib | mm10_v2_chr4_-_82705735_82705754 | 0.34 | 4.3e-02 | Click! |
Nfic | mm10_v2_chr10_-_81427114_81427187 | 0.33 | 4.8e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.0 | 3.1 | GO:1990523 | negative regulation of SMAD protein import into nucleus(GO:0060392) endothelial cell-cell adhesion(GO:0071603) negative regulation of sensory perception of pain(GO:1904057) bone regeneration(GO:1990523) |
1.0 | 2.9 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.7 | 3.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.7 | 2.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.7 | 9.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.7 | 2.0 | GO:1904020 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.6 | 3.2 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.6 | 1.7 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.6 | 2.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 1.5 | GO:0044240 | negative regulation of lipoprotein oxidation(GO:0034443) multicellular organism lipid catabolic process(GO:0044240) |
0.5 | 1.9 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.4 | 1.7 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.4 | 1.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.4 | 5.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 2.0 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.3 | 1.0 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 1.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 2.4 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.3 | 0.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.9 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.3 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.8 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) peptide antigen transport(GO:0046968) |
0.3 | 2.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 1.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.2 | 3.8 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.2 | 0.9 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 2.0 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 1.8 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.9 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.9 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.2 | 1.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 0.6 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 3.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 1.0 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.2 | 1.0 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 2.7 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.2 | 0.7 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.2 | 1.9 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 1.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 1.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 1.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 1.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.1 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 1.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.6 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
0.1 | 0.4 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.1 | 0.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 2.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.4 | GO:1904209 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 1.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.7 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.9 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.8 | GO:0015675 | nickel cation transport(GO:0015675) |
0.1 | 0.7 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.4 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.1 | 0.3 | GO:0003195 | tricuspid valve formation(GO:0003195) |
0.1 | 0.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 2.8 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.5 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
0.1 | 3.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.3 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) histone H3-R17 methylation(GO:0034971) negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.4 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.6 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.4 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.1 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 2.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 1.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.3 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.1 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.3 | GO:0010286 | heat acclimation(GO:0010286) |
0.1 | 0.1 | GO:1905072 | cardiac jelly development(GO:1905072) |
0.1 | 0.2 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.2 | GO:0070429 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.1 | 1.0 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.9 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.1 | GO:2000349 | negative regulation of CD40 signaling pathway(GO:2000349) |
0.1 | 4.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 1.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.4 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 1.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.9 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 2.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.8 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.2 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.1 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 1.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.3 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.5 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.0 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 1.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.0 | 0.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.2 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.0 | 0.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.5 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.0 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 2.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.0 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.0 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.3 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.0 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.0 | 1.4 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 2.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.3 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 1.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.3 | GO:0071285 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.0 | 0.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 1.5 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 2.4 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) |
0.0 | 1.5 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.8 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.5 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.3 | GO:0098969 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.7 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.3 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 2.2 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.0 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.0 | 0.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.2 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.4 | 2.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 1.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 3.8 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 5.3 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 6.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 4.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.6 | GO:0060187 | cell pole(GO:0060187) |
0.2 | 1.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 2.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.7 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) laminin-10 complex(GO:0043259) |
0.1 | 9.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 1.8 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.4 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.1 | 0.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 2.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 4.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.5 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 1.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 5.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 1.8 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 1.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 1.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 1.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.0 | 0.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 9.7 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 4.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 1.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 1.0 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 3.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 1.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 3.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.7 | GO:0005871 | kinesin complex(GO:0005871) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
1.3 | 10.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.0 | 3.0 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.6 | 4.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.6 | 1.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 2.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.5 | 1.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.4 | 5.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 2.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 1.9 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.3 | 2.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.3 | 1.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 1.3 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 0.9 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 2.0 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.9 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.2 | 1.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 1.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 5.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 1.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 3.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.8 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.2 | 0.8 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.2 | 1.9 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 1.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) RAGE receptor binding(GO:0050786) |
0.1 | 2.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 4.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 3.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 2.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.8 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.1 | 0.3 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.1 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.3 | GO:0005118 | sevenless binding(GO:0005118) |
0.1 | 3.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 2.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 2.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 1.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 3.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 3.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 2.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.1 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.2 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 1.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 2.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 1.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 6.2 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 1.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.3 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.0 | 0.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 2.0 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.1 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.0 | 0.7 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 1.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 1.1 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 2.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.7 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 2.2 | GO:0004386 | helicase activity(GO:0004386) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 5.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.9 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 8.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 2.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 6.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 5.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 6.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 3.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 3.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 6.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 3.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 3.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 4.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 2.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 2.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |